Division of Molecular Medicine and Gene Therapy
1 – 10 of 620
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Pharmacological inhibition of JNK-MAPK disrupts cigarette smoke-induced RUNX2/Galectin-3 -driven EMT and cancer stemness in lung adenocarcinoma cells
- Contribution to journal › Article
-
Mark
Cellular and biophysical barriers to lipid nanoparticle mediated delivery of RNA to the cytosol
- Contribution to journal › Article
-
Mark
Complex genotype-phenotype relationships shape the response to treatment of down syndrome childhood acute lymphoblastic leukaemia
- Contribution to journal › Article
-
Mark
2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia
- Contribution to journal › Scientific review
-
Mark
Disease characteristics and outcomes of acute myeloid leukemia in germline RUNX1 deficiency (Familial Platelet Disorder with associated Myeloid Malignancy)
- Contribution to journal › Article
-
Mark
Multitarget mechanism of MYC inhibition by the bacterial lon protease in disease
- Contribution to journal › Article
-
Mark
Reprogramming Stars #20 : Attenuating Cancer Cell Memory and Discovering Cancer Biomarkers with Cellular Reprogramming-An Interview with Dr. Jungsun Kim
- Contribution to journal › Article
-
Mark
Ontogeny-specific induction of the KMT2A::AFF1-fusion drives development of a distinct CD24 positive pre-leukemic state
- Contribution to journal › Article
-
Mark
Reprogramming Stars #22 : Cellular Reprogramming as a Route for Decoding Neurodegenerative Disorders-An Interview with Dr. Janelle Drouin-Ouellet
- Contribution to journal › Debate/Note/Editorial
-
Mark
Reprogramming Stars #21 : RNA Regulatory Mechanisms That Instruct Cell Identity-An Interview with Dr. Bruno Di Stefano
- Contribution to journal › Debate/Note/Editorial
